295 results on '"Minisola, G."'
Search Results
2. The Bridge Over the Blue Nile at Mekane Selam - Ethiopia
- Author
-
Codacci-Pisanelli, E., primary and Minisola, G., additional
- Published
- 2019
- Full Text
- View/download PDF
3. Approach in glucocorticoid-induced osteoporosis prevention: Results from the Italian multicenter observational EGEO study
- Author
-
Massafra, U., Migliaccio, S., Bancheri, C., Chiacchiararelli, F., Fantini, F., Leoni, F., Martin, L. S., Migliore, A., Muccifora, B., Napolitano, C., Pastore, R., Ragno, A., Ronzoni, S., Rotondi, M., Tibaldi, M., Villa, P., Vinicola, V., D’Erasmo, E., Falaschi, P., and Minisola, G.
- Published
- 2013
- Full Text
- View/download PDF
4. Vitamin D in the COVID 19 prevention and treatment: emerging evidence
- Author
-
D’Avolio, A., Isaia, G, Caprio, M, Fabbri, A, Falcone, S, Ferretti, E, Gardini, As, Infante, M, Maggiorotti, M, Migliaccio, S, Minisola, G, Morello, M, Ortore, V, Spera, G, and Tafaro, L
- Subjects
vitamin d ,covid-19 ,sars-cov-2 ,supplementation therapy ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Vitamin D and neurology ,Medicine ,Pharmacology ,business - Published
- 2021
5. The emerging problem of biological treatment in migrant and travelling populations: it is time to extend guidelines for the screening of infectious diseases
- Author
-
Bartalesi, F, Bartoloni, A, Bisoffi, Z, Spinicci, M, Giménez Sánchez, F, Muñoz, J, Richi, P, Minisola, G, Muñoz-Fernandez, S, and Matucci-Cerinic, M
- Published
- 2014
- Full Text
- View/download PDF
6. Oxaprozin: a NSAID able to inhibit the matrix metallo-proteinase activity
- Author
-
Barracchini, A., Minisola, G., Amicosante, G., and Franceschini, N.
- Published
- 2001
- Full Text
- View/download PDF
7. Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today
- Author
-
Bartalesi, F, Scire, C, Requena-Mendez, A, Abad, M, Buonfrate, D, Caporali, R, Conti, F, Diaz-Gonzalez, F, Fernandez-Espartero, C, Martinez-Fernandez, C, Mascarello, M, Generali, E, Minisola, G, Morrone, A, Munoz, J, Richi, P, Sakellariou, G, Coronas, J, Spinicci, M, Castelli, F, Bartoloni, A, Bisoffi, Z, Gimenez-Sanchez, F, Munoz-Fernandez, S, Matucci-Cerinic, M, Bartalesi F., Scire C. A., Requena-Mendez A., Abad M. A., Buonfrate D., Caporali R., Conti F., Diaz-Gonzalez F., Fernandez-Espartero C., Martinez-Fernandez C., Mascarello M., Generali E., Minisola G., Morrone A., Munoz J., Richi P., Sakellariou G., Coronas J. S., Spinicci M., Castelli F., Bartoloni A., Bisoffi Z., Gimenez-Sanchez F., Munoz-Fernandez S., Matucci-Cerinic M., Bartalesi, F, Scire, C, Requena-Mendez, A, Abad, M, Buonfrate, D, Caporali, R, Conti, F, Diaz-Gonzalez, F, Fernandez-Espartero, C, Martinez-Fernandez, C, Mascarello, M, Generali, E, Minisola, G, Morrone, A, Munoz, J, Richi, P, Sakellariou, G, Coronas, J, Spinicci, M, Castelli, F, Bartoloni, A, Bisoffi, Z, Gimenez-Sanchez, F, Munoz-Fernandez, S, Matucci-Cerinic, M, Bartalesi F., Scire C. A., Requena-Mendez A., Abad M. A., Buonfrate D., Caporali R., Conti F., Diaz-Gonzalez F., Fernandez-Espartero C., Martinez-Fernandez C., Mascarello M., Generali E., Minisola G., Morrone A., Munoz J., Richi P., Sakellariou G., Coronas J. S., Spinicci M., Castelli F., Bartoloni A., Bisoffi Z., Gimenez-Sanchez F., Munoz-Fernandez S., and Matucci-Cerinic M.
- Abstract
Objective Inflammatory arthritis needs infectious disease screening before starting a biologic agent, however, few data are known about migrant patients, who represent a peculiar population which requires a multidisciplinary approach among international health specialists and should also be considered by health authorities. For this reason, the Italian and Spanish Societies of Rheumatology (SIR and SER) and Tropical Medicine (SIMET and SEMTSI) promoted a multidisciplinary task force in order to produce specific recommendations about screening and advices to be considered in migrant patients with inflammatory arthritis candidate to receive biological therapy, according to their geographical origin. Methods The experts provided a prioritised list of research questions and the eligible spectrum of inflammatory arthritis, biologic drugs and infectious disease were defined in order to perform a systematic literature review. A search was made in Medline, Embase and Cochrane library, updated to March 2015. Ubiquitous infections and HBV, HCV, HIV and tuberculosis that are already considered in national and international recommendations, were not included. The strength of each recommendation was determined. Results The task force members agreed on 7 overarching principles. The risk of reactivation of selected potentially latent infectious disease was addressed in migrants with inflammatory arthritis candidates for biologics was considered and 15 potentially relevant infections were identified. Conclusion Fifteen disease-specific recommendations were formulated on the basis of high level of agreement among the experts panel.
- Published
- 2017
8. The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology
- Author
-
Migliore, A, Scire, C, Carmona, L, Beaumont, G, Bizzi, E, Branco, J, Carrara, G, Chevalier, X, Collaku, L, Aslanidis, S, Denisov, L, Di Matteo, L, Bianchi, G, Diracoglu, D, Frediani, B, Maheu, E, Martusevich, N, Bagnato, G, Scarpellini, M, Minisola, G, Akkoc, N, Ramonda, R, Barskova, T, Babic-Naglic, D, Muelas, J, Ionescu, R, Rashkov, R, Damjanov, N, Cerinic, M, Migliore A., Scire C. A., Carmona L., Beaumont G. H., Bizzi E., Branco J., Carrara G., Chevalier X., Collaku L., Aslanidis S., Denisov L., Di Matteo L., Bianchi G., Diracoglu D., Frediani B., Maheu E., Martusevich N., Bagnato G. F., Scarpellini M., Minisola G., Akkoc N., Ramonda R., Barskova T., Babic-Naglic D., Muelas J. V. M., Ionescu R., Rashkov R., Damjanov N., Cerinic M. M., Migliore, A, Scire, C, Carmona, L, Beaumont, G, Bizzi, E, Branco, J, Carrara, G, Chevalier, X, Collaku, L, Aslanidis, S, Denisov, L, Di Matteo, L, Bianchi, G, Diracoglu, D, Frediani, B, Maheu, E, Martusevich, N, Bagnato, G, Scarpellini, M, Minisola, G, Akkoc, N, Ramonda, R, Barskova, T, Babic-Naglic, D, Muelas, J, Ionescu, R, Rashkov, R, Damjanov, N, Cerinic, M, Migliore A., Scire C. A., Carmona L., Beaumont G. H., Bizzi E., Branco J., Carrara G., Chevalier X., Collaku L., Aslanidis S., Denisov L., Di Matteo L., Bianchi G., Diracoglu D., Frediani B., Maheu E., Martusevich N., Bagnato G. F., Scarpellini M., Minisola G., Akkoc N., Ramonda R., Barskova T., Babic-Naglic D., Muelas J. V. M., Ionescu R., Rashkov R., Damjanov N., and Cerinic M. M.
- Abstract
The aim of this study was to establish consensus for potential early symptomatic knee osteoarthritis (ESKOA) clinical definition and referral criteria from primary care to rheumatologists, based on available data from literature and a qualitative approach, in order to perform studies on patients fulfilling such criteria and to validate the obtained ESKOA definition. A complex methodological approach was followed including: (1) three focus groups (FG), including expert clinicians, researchers and patients; (2) a systematic literature review (SLR); (3) two discussion groups followed by a Delphi survey. FG and SLR were performed in parallel to inform discussion groups in order to identify relevant constructs to be included in the modified Delphi survey. ESKOA is defined in the presence of: (a) two mandatory symptoms (knee pain in the absence of any recent trauma or injury and very short joint stiffness, lasting for less than 10 min, when starting movement) even in the absence of risk factors, or (b) knee pain, and 1 or 2 risk factors or (c) three or more risk factors in the presence of at least one mandatory symptom, with symptoms lasting less than 6 months. These criteria are applicable in the absence of active inflammatory arthritis, generalized pain, Kellgren-Lawrence grade >0, any recent knee trauma or injury, and age lower than 40 years. Knee pain in the absence of any recent trauma lasting for less than 6 months was considered as the referral criterion to the rheumatologist for the suspicion of ESKOA. This consensus process has identified provisional clinical definition of ESKOA and defined potential referral criterion to rheumatologist, in order to test ESKOA obtained definition in prospective validation studies.
- Published
- 2017
9. Cerebellar tumour presenting with pathological laughter and gelastic syncope
- Author
-
Famularo, G., Corsi, F. M., Minisola, G., De Simone, C., and Nicotra, G. C.
- Published
- 2007
10. Two Single-Nucleotide Polymorphisms in the 5′ and 3′ Ends of the Osteopontin Gene Contribute to Susceptibility to Systemic Lupus Erythematosus
- Author
-
DʼAlfonso, S., Barizzone, N., Giordano, M., Chiocchetti, A., Magnani, C., Castelli, L., Indelicato, M., Giacopelli, F., Marchini, M., Scorza, R., Danieli, M. G., Cappelli, M., Migliaresi, S., Bigliardo, B., Sabbadini, M. G., Baldissera, E., Galeazzi, M., Sebastiani, G. D., Minisola, G., Ravazzolo, R., Dianzani, U., and Momigliano-Richiardi, P.
- Published
- 2005
11. Fatal rupture of an inflammatory arterial aneurysm in a patient with Wegenerʼs granulomatosis
- Author
-
Famularo, G, De Cata, A, Bracci, M, Minisola, G, De Simone, C, and Nicotra, G C
- Published
- 2004
12. Fluorodeoxyglucose positron emission tomography for the diagnosis of giant cell arteritis
- Author
-
Famularo, G., Minisola, G., and De Simone, C.
- Published
- 2004
13. Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: Results of an Italian observational study
- Author
-
Caporali, R., Idolazzi, L., Bombardieri, S., Ferraccioli, G., Gerli, R., Govoni, M., Matucci-Cerinic, M., Pomponio, G., Salaffi, F., Tirri, R., Benaglio, F., Bianchino, L., Sarzi-Puttini, P., Adami, S., Afeltra, A., Altomonte, L., Arrigoni, E., Bagnato, G., Bianchi, G., Bucci, R. N., Caminiti, M., Cantini, F., Caputo, D., Carlino, G., Clerico, P., Colombelli, P., Corsaro, S. M., D Alessandro, G., Riso, L., Silva, S., D Errico, T., Di Matteo, L., Ferri, C., Foti, R., Fusaro, E., Gabrielli, A., Giacomelli, R., Lunardi, C., Malavolta, N., Martin Martin, L. S., Massarotti, M. S., Mazzone, A., Meschini, C., Migliore, A., Minisola, G., Monti, G., Muratore, M., Paoletti, F., Pappone, N., Passiu, G., Mario Pirisi, Pistone, G., Pozzi, M. R., Prandini, P., Provenzano, G., Ricioppo, A., Romeo, N., Russo, R., Saviola, G., Semeraro, A., Tartarelli, G., Tomietto, P., Valentini, G., Zuccaro, C., Caporali, Roberto, Idolazzi, Luca, Bombardieri, Stefano, Ferraccioli, Gianfranco, Gerli, Roberto, Govoni, Marcello, Matucci-Cerinic, Marco, Pomponio, Giovanni, Salaffi, Fausto, Tirri, Rosella, Benaglio, Francesca, Bianchino, Laura, Sarzi-Puttini, Piercarlo, Caporali, R., Adami, S., Afeltra, A., Altomonte, L., Arrigoni, E., Bagnato, G., Bianchi, G., Bombardieri, S., Bucci, R. N., Caminiti, M., Cantini, F., Caputo, D., Carlino, G., Clerico, P., Colombelli, P., Corsaro, S. M., D'Alessandro, G., De Riso, L., De Silva, S., D'Errico, T., Di Matteo, L., Ferraccioli, G., Ferri, C., Foti, R., Fusaro, E., Gabrielli, A., Gerli, R., Giacomelli, R., Govoni, M., Lunardi, C., Malavolta, N., Martin Martin, L. S., Massarotti, M. S., Matucci-Cerinic, M., Mazzone, A., Meschini, C., Migliore, A., Minisola, G., Monti, G., Muratore, M., Paoletti, F., Pappone, N., Passiu, G., Pirisi, M., Pistone, G., Pozzi, M. R., Prandini, P., Provenzano, G., Ricioppo, A., Romeo, N., Russo, R., Salaffi, F., Sarzi-Puttini, P., Saviola, G., Semeraro, A., Tartarelli, G., Tomietto, P., Valentini, G., and Zuccaro, C.
- Subjects
Rheumatology ,Interleukin-6 ,Immunology ,Immunology and Allergy ,Tocilizumab ,Monotherapy ,Rheumatoid arthriti - Abstract
Objective To describe the effectiveness and safety of tocilizumab (TCZ), an interleukin-6 receptor inhibitor, in a cohort of patients with rheumatoid arthritis (RA) recruited in clinical practice. Methods TRUST was an observational study in RA patients who started treatment with TCZ in the 6 months prior to site activation and were still on treatment at start of study; patients were followed up to 12 months after the first TCZ infusion. Results 322 RA patients were enrolled in 59 Italian centres (mean age: 55.8 years; mean disease duration: 120.5 months; baseline DAS28: 5.3). After 6 months of TCZ treatment, patients achieving low disease activity (DAS28 ≤3.2; 57.52%) or disease remission (DAS28 < 2.6; 38.05%) were 216 out of 226 patients with available DAS28 (p < 0.001). No statistically significant differences were found in mean DAS28 and HAQ score changes from baseline (start of TCZ treatment) to study end between patients previously inadequately responding to disease-modifyinganti-rheumatic drugs (DMARD-IR) or to DMARDs plus tumour necrosis factor inhibitors (DMARD +TNFi-IR): both patient populations responded to TCZ. A statistically significant decrease in mean VAS Fatigue score (48.4 vs. 34.7; p=0.0025) at month 6 was observed. In patients treated with TCZ as monotherapy (32.61%), DAS28, VAS fatigue and HAQ scores decreased from baseline to any post-baseline time point. Overall, 62 patients (19.3%) prematurely discontinued TCZ treatment, 24 (7.5%) for safety reasons. Drug-related adverse events occurred in 92 patients (28.6%) (mostly 3 hypercholesterolaemia and leucopenia) and drug-related serious adverse events in 11 patients (3.4%). Conclusion This study confirms the good effectiveness and safety profile of TCZ in real life RA patient care.
- Published
- 2017
14. Development and First Validation of a Disease Activity Score for Gout
- Author
-
Scire, C, Carrara, G, Viroli, C, Cimmino, M, Taylor, W, Manara, M, Govoni, M, Salaffi, F, Punzi, L, Montecucco, C, Matucci-Cerinic, M, Minisola, G, Ariani, A, Galossi, A, Lauriti, C, Fracassi, E, Idolazzi, L, Bardelli, M, Selvi, E, Tirri, E, Furini, F, Inverardi, F, Calabro, A, Porta, F, Bittelli, R, Venturino, F, Capsoni, F, Prevete, I, Sebastiani, G, Selmi, C, Fabbriciani, G, D'Avola, G, Botticella, G, Serale, F, Seminara, G, D'Alessandro, G, Santo, L, Longato, L, Zaccara, E, Sinigaglia, L, Atteritano, M, Broggini, M, Caprioli, M, Favero, M, Salli, S, Scarati, M, Parisi, S, Malavolta, N, Corvaglia, S, Scarpato, S, Veneto, V, Scire C. A., Carrara G., Viroli C., Cimmino M. A., Taylor W. J., Manara M., Govoni M., Salaffi F., Punzi L., Montecucco C., Matucci-Cerinic M., Minisola G., Ariani A., Galossi A., Lauriti C., Fracassi E., Idolazzi L., Bardelli M., Selvi E., Tirri E., Furini F., Inverardi F., Calabro A., Porta F., Bittelli R., Venturino F., Capsoni F., Prevete I., Sebastiani G., Selmi C., Fabbriciani G., D'Avola G., Botticella G., Serale F., Seminara G., D'Alessandro G., Santo L., Longato L., Zaccara E., Sinigaglia L., Atteritano M., Broggini M., Caprioli M., Favero M., Salli S., Scarati M., Parisi S., Malavolta N., Corvaglia S., Scarpato S., Veneto V., Scire, C, Carrara, G, Viroli, C, Cimmino, M, Taylor, W, Manara, M, Govoni, M, Salaffi, F, Punzi, L, Montecucco, C, Matucci-Cerinic, M, Minisola, G, Ariani, A, Galossi, A, Lauriti, C, Fracassi, E, Idolazzi, L, Bardelli, M, Selvi, E, Tirri, E, Furini, F, Inverardi, F, Calabro, A, Porta, F, Bittelli, R, Venturino, F, Capsoni, F, Prevete, I, Sebastiani, G, Selmi, C, Fabbriciani, G, D'Avola, G, Botticella, G, Serale, F, Seminara, G, D'Alessandro, G, Santo, L, Longato, L, Zaccara, E, Sinigaglia, L, Atteritano, M, Broggini, M, Caprioli, M, Favero, M, Salli, S, Scarati, M, Parisi, S, Malavolta, N, Corvaglia, S, Scarpato, S, Veneto, V, Scire C. A., Carrara G., Viroli C., Cimmino M. A., Taylor W. J., Manara M., Govoni M., Salaffi F., Punzi L., Montecucco C., Matucci-Cerinic M., Minisola G., Ariani A., Galossi A., Lauriti C., Fracassi E., Idolazzi L., Bardelli M., Selvi E., Tirri E., Furini F., Inverardi F., Calabro A., Porta F., Bittelli R., Venturino F., Capsoni F., Prevete I., Sebastiani G., Selmi C., Fabbriciani G., D'Avola G., Botticella G., Serale F., Seminara G., D'Alessandro G., Santo L., Longato L., Zaccara E., Sinigaglia L., Atteritano M., Broggini M., Caprioli M., Favero M., Salli S., Scarati M., Parisi S., Malavolta N., Corvaglia S., Scarpato S., and Veneto V.
- Abstract
Objective: To develop a new composite disease activity score for gout and provide its first validation. Methods: Disease activity has been defined as the ongoing presence of urate deposits that lead to acute arthritis and joint damage. Every measure for each Outcome Measures in Rheumatology core domain was considered. A 3-step approach (factor analysis, linear discriminant analysis, and linear regression) was applied to derive the Gout Activity Score (GAS). Decision to change treatment or 6-month flare count were used as the surrogate criteria of high disease activity. Baseline and 12-month followup data of 446 patients included in the Kick-Off of the Italian Network for Gout cohort were used. Construct- and criterion-related validity were tested. External validation on an independent sample is reported. Results: Factor analysis identified 5 factors: patient-reported outcomes, joint examination, flares, tophi, and serum uric acid (sUA). Discriminant function analysis resulted in a correct classification of 79%. Linear regression analysis identified a first candidate GAS including 12-month flare count, sUA, visual analog scale (VAS) of pain, VAS global activity assessment, swollen and tender joint counts, and a cumulative measure of tophi. Alternative scores were also developed. The developed GAS demonstrated a good correlation with functional disability (criterion validity) and discrimination between patient- and physician-reported measures of active disease (construct validity). The results were reproduced in the external sample. Conclusion: This study developed and validated a composite measure of disease activity in gout. Further testing is required to confirm its generalizability, responsiveness, and usefulness in assisting with clinical decisions.
- Published
- 2016
15. Serum osteocalcin in metabolic bone diseases: What is its real significance?
- Author
-
Minisola, S., Carnevale, V., Pacitti, M. T., Romagnoli, E., Scarnecchia, L., Rosso, R., Minisola, G., and Mazzuoli, G. F.
- Published
- 1993
- Full Text
- View/download PDF
16. Lifestyle and dietary habits of patients with gout followed in rheumatology settings
- Author
-
Manara, M, Carrara, G, Scire, C, Cimmino, M, Govoni, M, Montecucco, C, Matucci-Cerinic, M, Minisola, G, Ariani, A, Galossi, A, Lauriti, C, Fracassi, E, Idolazzi, L, Bardelli, M, Selvi, E, Tirri, E, Furini, F, Inverardi, F, Calabro, A, Porta, F, Bittelli, R, Venturino, F, Capsoni, F, Prevete, I, Sebastiani, G, Selmi, C, Fabbriciani, G, D'Avola, G, Botticella, G, Serale, F, Seminara, G, D'Alessandro, G, Santo, L, Longato, L, Zaccara, E, Sinigaglia, L, Atteritano, M, Broggini, M, Caprioli, M, Favero, M, Salli, S, Scarati, M, Parisi, S, Malavolta, N, Corvaglia, S, Scarpato, S, Veneto, V, Manara M., Carrara G., Scire C. A., Cimmino M. A., Govoni M., Montecucco C., Matucci-Cerinic M., Minisola G., Ariani A., Galossi A., Lauriti C., Fracassi E., Idolazzi L., Bardelli M., Selvi E., Tirri E., Furini F., Inverardi F., Calabro A., Porta F., Bittelli R., Venturino F., Capsoni F., Prevete I., Sebastiani G., Selmi C., Fabbriciani G., D'Avola G., Botticella G., Serale F., Seminara G., D'Alessandro G., Santo L., Longato L., Zaccara E., Sinigaglia L., Atteritano M., Broggini M., Caprioli M., Favero M., Salli S., Scarati M., Parisi S., Malavolta N., Corvaglia S., Scarpato S., Veneto V., Manara, M, Carrara, G, Scire, C, Cimmino, M, Govoni, M, Montecucco, C, Matucci-Cerinic, M, Minisola, G, Ariani, A, Galossi, A, Lauriti, C, Fracassi, E, Idolazzi, L, Bardelli, M, Selvi, E, Tirri, E, Furini, F, Inverardi, F, Calabro, A, Porta, F, Bittelli, R, Venturino, F, Capsoni, F, Prevete, I, Sebastiani, G, Selmi, C, Fabbriciani, G, D'Avola, G, Botticella, G, Serale, F, Seminara, G, D'Alessandro, G, Santo, L, Longato, L, Zaccara, E, Sinigaglia, L, Atteritano, M, Broggini, M, Caprioli, M, Favero, M, Salli, S, Scarati, M, Parisi, S, Malavolta, N, Corvaglia, S, Scarpato, S, Veneto, V, Manara M., Carrara G., Scire C. A., Cimmino M. A., Govoni M., Montecucco C., Matucci-Cerinic M., Minisola G., Ariani A., Galossi A., Lauriti C., Fracassi E., Idolazzi L., Bardelli M., Selvi E., Tirri E., Furini F., Inverardi F., Calabro A., Porta F., Bittelli R., Venturino F., Capsoni F., Prevete I., Sebastiani G., Selmi C., Fabbriciani G., D'Avola G., Botticella G., Serale F., Seminara G., D'Alessandro G., Santo L., Longato L., Zaccara E., Sinigaglia L., Atteritano M., Broggini M., Caprioli M., Favero M., Salli S., Scarati M., Parisi S., Malavolta N., Corvaglia S., Scarpato S., and Veneto V.
- Abstract
Diet and lifestyles modification are core aspects of the non-pharmacological management of gout, but a poor consistency with suggested guidelines is reported. This study aimed to investigate dietary and lifestyle habits of patients with gout followed in rheumatology settings. Data were retrieved from the baseline dataset of the KING study, a multicentre cohort study of patients with gout followed in rheumatology settings. Dietary habits were assessed with the Italian National Institute of Statistics (ISTAT) food-frequency questionnaire and compared with reported data about general population. The relative increase of exposure was estimated by standardized prevalence ratios adjusted for gender, age and geographical distribution. The study population included 446 patients, with a mean age of 63.9 years and a M/F ratio of 9:1. Compared to the Italian population, gouty patients showed a higher prevalence of obesity [1.82 (1.52-2.18)] and a higher consumption of wine [1.85 (1.48-2.32)] and beer [2.21 (1.68-2.90)], but a lower prevalence of smoking and a lower intake of liquor. They showed a lower intake of red meat [0.80 (0.71-0.91)], but a similar intake of other tested dietary factors. Gouty patients’ lifestyle is still partially different from the recommended.
- Published
- 2015
17. FRI0373 Long-term follow-up of 320 children born to mothers with systemic autoimmune diseases: a multicentre italian survey from 24 rheumatology centres
- Author
-
Lazzaroni, M.G., primary, Nalli, C., additional, Andreoli, L., additional, Carini, C., additional, Bartoloni-Bocci, E., additional, Gerli, R., additional, Chighizola, C.B., additional, Gerosa, M., additional, Meroni, P.L., additional, Sinigaglia, L., additional, Conigliaro, P., additional, Perricone, R., additional, Corrado, A., additional, Cantatore, F., additional, D’Angelo, S., additional, Favaro, M., additional, Larosa, M., additional, Doria, A., additional, Ruffatti, A., additional, Generali, E., additional, Selmi, C., additional, Meroni, M., additional, Cutolo, M., additional, Padovan, M., additional, Govoni, M., additional, Pazzola, G., additional, Salvarani, C., additional, Peccatori, S., additional, Paolazzi, G., additional, Prevete, I., additional, Sebastiani, G.D., additional, Minisola, G., additional, Brucato, A., additional, Ramoni, V., additional, Caporali, R., additional, Montecucco, C., additional, Tani, C., additional, Signorini, V., additional, Mosca, M., additional, Trevisani, M., additional, Malavolta, N., additional, Vadacca, M., additional, Afeltra, A., additional, Vivaldelli, E., additional, Maier, A., additional, Visalli, E., additional, Foti, R., additional, Zuliani, L., additional, Gabrielli, A., additional, Campochiaro, C., additional, Baldissera, E., additional, Sabbadini, M.G., additional, Romeo, N., additional, and Tincani, A., additional
- Published
- 2018
- Full Text
- View/download PDF
18. PS4:79 Long-term follow-up of 320 chilren born to mothers with systemic autoimmune diseases: a multicentre survey from 24 rheumatology centres in italy
- Author
-
Lazzaroni, MG, primary, Nalli, C, additional, Andreoli, L, additional, Carini, C, additional, Dall’Ara, F, additional, Rodrigues, M, additional, Bartoloni Bocci, E, additional, Gerli, R, additional, Chighizola, CB, additional, Gerosa, M, additional, Meroni, PL, additional, Sinigaglia, L, additional, Conigliaro, P, additional, Perricone, R, additional, Corrado, A, additional, Cantatore, F, additional, D’Angelo, S, additional, Favaro, M, additional, Larosa, M, additional, Doria, A, additional, Ruffatti, A, additional, Generali, E, additional, Selmi, C, additional, Meroni, M, additional, Cutolo, M, additional, Padovan, M, additional, Govoni, M, additional, Pazzola, G, additional, Salvarani, C, additional, Peccatori, S, additional, Prevete, I, additional, Minisola, G, additional, Sebastiani, GD, additional, Brucato, A, additional, Ramoni, V, additional, Caporali, R, additional, Montecucco, C, additional, Tani, C, additional, Signorini, V, additional, Mosca, M, additional, Trevisani, M, additional, Malavolta, N, additional, Vadacca, M, additional, Afeltra, A, additional, Vivaldelli, E, additional, Maier, A, additional, Visalli, E, additional, Foti, R, additional, Zuliani, L, additional, Gabrielli, A, additional, Campochiaro, C, additional, Baldissera, E, additional, Sabbadini, MG, additional, Romeo, N, additional, and Tincani, A, additional
- Published
- 2018
- Full Text
- View/download PDF
19. Calcium intake in the Mediterranean region
- Author
-
Falaschi, P., Maggi, S., Tafaro, L., Noale, M., de Marinis, E., Gonnelli, S., Nuti, R., Arioli, G., Barbagallo, M., Dalle Carbonare, L., Diaz-Curiel, M., Sosa, M., Gandolini, G., Iolascon, G., Letizia Mauro, G., Minisola, G., Crepaldi, G., Falaschi, P., Maggi, S., Tafaro, L., Noale, M., de Marinis, E., Gonnelli, S., Nuti, R., Arioli, G., Barbagallo, M., Dalle Carbonare, L., Diaz-Curiel, M., Sosa, M., Gandolini, G., Iolascon, G., Letizia Mauro, G., Minisola, G., and Crepaldi, G.
- Subjects
Settore MED/34 - Medicina Fisica E Riabilitativa ,Calcium intake, BMD, family fracture history, ospeopenic, osteoporotic - Abstract
A deficiency in calcium intake, is considered an important risk factor for the development of osteoporosis. Since the human body cannot produce calcium, individuals are recommended to maintain an adequate daily intake. The aim of the “Calcium Intake in the Mediterranean Region” Study is to evaluate the mean calcium intake in men and women between 40 and 80 residing in various areas of the Mediterranean basin. Enrolled subjects have been asked to fill out a self-administered questionnaire to evaluate the mean daily calcium intake from food, principle risk factors for osteoporosis were registered. A dual- energy X-ray absorptiometry (DEXA) has also been carried out to evaluate bone mineral density (BMD). During the recruitment period between March 2011 and February 2014, were enrolled 982 subjects. 90% are female, the average age is 60.4±10.0 years.The mean daily calcium intake is 1005 ± 449.9mg. Over the 63% of the sample assume a lower calcium intake compared to the recommended dietary allowance (RDA), there are statistically significant gender differences (p < 0.0001) because men have a greater calcium assumption. There is also a significant decreasing trend of assumption with age (p < 0.0001). Calcium Intake is lower in osteopenic and osteoporotic subjects compared to subjects with normal BMD (p=0.0048). Factors significantly associated with a low calcium intake are: sex, age, body mass index, previous fracture, family fracture history. Our study remarks the importance of calcium for the bone health and at the same time, confirms that Mediterranean women over 60 years of age need more calcium daily intake.
- Published
- 2014
20. A PROPOSAL FOR THE DEFINITION OF EARLY SYMPTOMATIC KNEE OSTEOARTHRITIS FROM AN INTERNATIONAL CONSENSUS PROMOTED BY THE ITALIAN SOCIETY FOR RHEUMATOLOGY (SIR)
- Author
-
Carmona, L., Akkoc, N., Minisola, G., Scarpellini, M., Bagnato, G. F., Martusevich, N., Maheu, E., Frediani, B., DIRAÇOĞLU, Demirhan, Bianchi, G., Di Matteo, L., Denisov, L., Aslanidis, S., Collaku, L., Barskova, T., Babic-Naglic, D., Moreno Muelas, J. V., Herrero-Beaumont, G., Matucci-Cerinic, M., Rashkov, R., Ionescu, R., Damjanov, N., Chevalier, X., Bizzi, E., Ramonda, R., Branco, J., Migliore, A., and Scire, C. A.
- Published
- 2016
21. Study of vitamin D status of rheumatoid arthritis patients Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)
- Author
-
Frediani, B, Rossini, Maurizio, Adami, Silvano, Bianchi, G, Di Munno, O, Sinigaglia, L, Antonelli, M, Minisola, G, and delle Malattie Metaboliche dello Scheletro, SIR per lo Studio dell'Osteoporosi e.
- Subjects
rheumatoid arthritis ,Adult ,Male ,medicine.medical_specialty ,lcsh:Internal medicine ,Osteoporosis ,lcsh:Medicine ,Disease ,Bone remodeling ,Metabolic bone disease ,Arthritis, Rheumatoid ,Absorptiometry, Photon ,Rheumatology ,Internal medicine ,medicine ,Vitamin D and neurology ,Humans ,Femur ,Vitamin D ,lcsh:RC31-1245 ,Societies, Medical ,Aged ,Lumbar Vertebrae ,Bone Density Conservation Agents ,business.industry ,Multiple sclerosis ,vitamin D ,metabolic bone disease ,lcsh:R ,Middle Aged ,Alkaline Phosphatase ,medicine.disease ,Bone Diseases, Metabolic ,Cross-Sectional Studies ,Italy ,Rheumatoid arthritis ,Immunology ,Female ,business - Abstract
The fundamental role of Vitamin D has been long known in regulating calcium homeostasis and bone metabolism. An increased contribution of Vitamin D was recently described in association with a lower incidence of Rheumatoid Arthritis (RA). This must not be surprising, as the immunomodulating effects of Vitamin D are clear, which have been attributed protective effects in autoimmune disorders such as some chronic inflammatory bowel diseases, multiple sclerosis and type I diabetes. An interaction was suggested between Vitamin D metabolism and inflammation indexes through mediation of TNF-alpha which is also especially involved in osteoclastic resorption and therefore in bone loss processes. Some preliminary data would indicate an association between seasonal changes of Vitamin D serum levels, latitude and disease activity (DAS28) in RA patients. Consequently, the Osteoporosis and Metabolic Bone Diseases Study Group of SIR believes that there are grounded reasons for assessing the Vitamin D status of RA patients in order to investigate whether this is to be related to physiopathological and clinical aspects of disease other than those of bone involvement. Primary end point of the study will be to assess the levels of 25 OH Vitamin D in RA patients. Secondary endpoints will include correlation with dis-ease activity, densitometry values and bone turnover. The cross-sectional study will enroll patients of both sex genders, age ranging between 30 and 75 years according to the 1988 ACR criteria, onset of symptoms at least 2 years prior to study enrollment. Patients will be excluded suffering from osteo-metabolic diseases, liver and kidney insufficiency and those administered Vitamin D boli in the previous 12 months. Disease activity will be evaluated with the HAQ. Hemato-chemical tests and femoral and lumbar bone densitometry will be performed, unless recently undergone by patients. Blood levels of 25 OH C Vitamin D and PHT and of the two bone remodelling markers (bone alkaline phosphatase and serum CTX) will be measured, as well. Patient enrollment will start on February 2007 and will last 4 months. By the end of 2007 the study will be concluded and results will be published.
- Published
- 2011
22. Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet Database
- Author
-
Scire', C, Caporali, R, Sarzi Puttini, P, Frediani, B, Di Franco, M, Tincani, A, Sinigaglia, L, Sfriso, P, Tirri, R, Bellis, E, Delsante, G, Porru, G, Salaffi, F, Giuggioli, D, Rossini, M, Todoerti, M, Bazzichi, L, Govoni, M, Gerli, R, Raschetti, R, Minisola, G, Montecucco, C, Todesco, S, SCIRE', Carlo Alberto, Caporali R, Sarzi Puttini P, Frediani B, Di Franco M, Tincani A, Sinigaglia L, Sfriso P, Tirri R, Bellis E, Delsante G, Porru G, Salaffi F, Giuggioli D, Rossini M, Todoerti M, Bazzichi L, GOVONI, Marcello, Gerli R, Raschetti R, Minisola G, Montecucco C, Todesco S., Scire', C, Caporali, R, Sarzi Puttini, P, Frediani, B, Di Franco, M, Tincani, A, Sinigaglia, L, Sfriso, P, Tirri, R, Bellis, E, Delsante, G, Porru, G, Salaffi, F, Giuggioli, D, Rossini, M, Todoerti, M, Bazzichi, L, Govoni, M, Gerli, R, Raschetti, R, Minisola, G, Montecucco, C, Todesco, S, SCIRE', Carlo Alberto, Caporali R, Sarzi Puttini P, Frediani B, Di Franco M, Tincani A, Sinigaglia L, Sfriso P, Tirri R, Bellis E, Delsante G, Porru G, Salaffi F, Giuggioli D, Rossini M, Todoerti M, Bazzichi L, GOVONI, Marcello, Gerli R, Raschetti R, Minisola G, Montecucco C, and Todesco S.
- Abstract
Objective: To compare drug survival of different anti-TNF drugs (inliximab, INF, etanercept, ETA, and adalimumab, ADA) in rheumatoid arthritis (RA) and spondyloarthritis (SpA) by analysing data collected from an Italian multicentre observational cohort study.Methods: All patients with RA or SpA registered in the MonitorNet database who started their irst course of anti-TNF therapy were included.Overall drug survival was measured, along with speciic reasons of discontinuation (ineficacy or adverse events).A first set of analyses using RA as reference category assessed the relationship between diagnosis and drug survival.A second set of analyses stratiied by diagnosis (RA and SpA) used INF as reference drug.Adjustment for confounders was performed.The results are presented as adjusted hazard ratios (adjHR) and 95% conidence intervals (95%CI).Results: 2640 RA patients and 1220 SpA patients with a median follow-up of 17 months (IQR 7.2-33.4) were included in the analyses.Patients with a diagnosis of SpA showed a lower risk of drug discontinuation with an adjHR (95%CI) of 0.81 (0.73, 0.90).In SpA, the subset of patients with ankylosing spondylitis (AS) showed the best survival on treatment.In RA, both ETA and ADA showed a signiicantly lower probability of withdrawal when compared to INF [adjHR (95%CI) 0.46 (0.38, 0.56) and 0.68 (0.57, 0.81), respectively].Similar results were found in SpA.Conclusion: Drug survival for SpA is longer than that in RA mainly due to the AS subgroup.In both RA and SpA, ETA and ADA showed a better retention on treatment when compared to INF.
- Published
- 2013
23. Italian Society of Rheumatology recommendations for the management of gout
- Author
-
Manara, M, Bortoluzzi, A, Favero, M, Prevete, I, Scire', C, Bianchi, G, Borghi, C, Cimmino, M, D'Avola, G, Desideri, G, Di Giacinto, G, Govoni, M, Grassi, W, Lombardi, A, Marangella, M, Matucci Cerinic, M, Medea, G, Ramonda, R, Spadaro, A, Punzi, L, Minisola, G, Manara M, BORTOLUZZI, Alessandra, Favero M, Prevete I, SCIRE', Carlo Alberto, Bianchi G, Borghi C, Cimmino MA, D'Avola GM, Desideri G, Di Giacinto G, GOVONI, Marcello, Grassi W, Lombardi A, Marangella M, Matucci Cerinic M, Medea G, Ramonda R, Spadaro A, Punzi L, Minisola G., Manara, M, Bortoluzzi, A, Favero, M, Prevete, I, Scire', C, Bianchi, G, Borghi, C, Cimmino, M, D'Avola, G, Desideri, G, Di Giacinto, G, Govoni, M, Grassi, W, Lombardi, A, Marangella, M, Matucci Cerinic, M, Medea, G, Ramonda, R, Spadaro, A, Punzi, L, Minisola, G, Manara M, BORTOLUZZI, Alessandra, Favero M, Prevete I, SCIRE', Carlo Alberto, Bianchi G, Borghi C, Cimmino MA, D'Avola GM, Desideri G, Di Giacinto G, GOVONI, Marcello, Grassi W, Lombardi A, Marangella M, Matucci Cerinic M, Medea G, Ramonda R, Spadaro A, Punzi L, and Minisola G.
- Abstract
Objective: Gout is the most common arthritis in adults. Despite the availability of valid therapeutic options, the management of patients with gout is still suboptimal. The Italian Society of Rheumatology (SIR) aimed to update, adapt to national contest and disseminate the 2006 EULAR recommendations for the management of gout. Methods: The multidisciplinary group of experts included rheumatologists, general practitioners, internists, geriatricians, nephrologists, cardiologists and evidence-based medicine experts. To maintain consistency with EULAR recommendations, a similar methodology was utilized by the Italian group. The original propositions were translated in Italian and priority research queries were identified through a Delphi consensus approach. A systematic search was conducted for selected queries. Efficacy and safety data on drugs reported in RCTs were combined in a meta-analysis where feasible. The strength of recommendation was measured by utilising the EULAR ordinal and visual analogue scales. Results: The original 12 propositions were translated and adapted to Italian context. Further evidences were collected about the role of diet in the non-pharmacological treatment of gout and the efficacy of oral corticosteroids and low-dose colchicine in the management of acute attacks. Statements concerning uricosuric treatments were withdrawn and replaced with a proposition focused on a new urate lowering agent, febuxostat. A research agenda was developed to identify topics still not adequately investigated concerning the management of gout. Conclusions: The SIR has developed updated recommendations for the management of gout adapted to the Italian healthcare system. Their implementation in clinical practice is expected to improve the management of patients with gout.
- Published
- 2013
24. Italian society for Rheumatology recommendations for the management of hand osteoarthritis
- Author
-
Manara, M, Bortoluzzi, A, Favero, M, Prevete, I, Scire', C, Bagnato, G, Bianchi, G, Ceruso, M, Checchia, G, D'Avola, G, Di Giacinto, G, Frediani, B, Lombardi, A, Mannoni, A, Mascheroni, G, Matucci Cerinic, M, Punzi, L, Richelmi, P, Scarpellini, M, Torretta, F, Migliore, A, Ramonda, R, Minisola, G, BORTOLUZZI, Alessandra, Favero, M., Prevete, I., SCIRE', Carlo Alberto, Bagnato, G., Bianchi, G., Ceruso, M., Checchia, G. A., D'Avola, G. M., Di Giacinto, G., Frediani, B., Lombardi, A., Mannoni, A., Mascheroni, G., Matucci Cerinic, M. M., Punzi, L., Richelmi, P., Scarpellini, M., Torretta, F., Migliore, A., Ramonda, R., Minisola, G., Manara, M, Bortoluzzi, A, Favero, M, Prevete, I, Scire', C, Bagnato, G, Bianchi, G, Ceruso, M, Checchia, G, D'Avola, G, Di Giacinto, G, Frediani, B, Lombardi, A, Mannoni, A, Mascheroni, G, Matucci Cerinic, M, Punzi, L, Richelmi, P, Scarpellini, M, Torretta, F, Migliore, A, Ramonda, R, Minisola, G, BORTOLUZZI, Alessandra, Favero, M., Prevete, I., SCIRE', Carlo Alberto, Bagnato, G., Bianchi, G., Ceruso, M., Checchia, G. A., D'Avola, G. M., Di Giacinto, G., Frediani, B., Lombardi, A., Mannoni, A., Mascheroni, G., Matucci Cerinic, M. M., Punzi, L., Richelmi, P., Scarpellini, M., Torretta, F., Migliore, A., Ramonda, R., and Minisola, G.
- Abstract
Hand osteoarthritis (OA) is a common and potentially disabling disease, with different features from hip and knee OA so that a specific therapeutic approach is required. Evidence based recommendations for the management of hand OA were developed by the European League Against Rheumatism (EULAR) in 2006. The Italian Society for Rheumatology (SIR) aimed to update, adapt to national contest and disseminate the EULAR recommendations for the management of hand OA. The multidisciplinary group of experts included specialists involved in the management of patients with hand OA. In order to maintain consistency with EULAR recommendations, a similar methodology was utilized by the Italian group. The original propositions were reformulated in terms of a search query and for every recommendation a systematic search was conducted updating EULAR recommendations' review. The propositions were translated in Italian and reformulated basing on collected evidences and expert opinion. The strength of recommendation was measured for each proposition with the EULAR ordinal and visual analogue scales. The original 11 propositions of EULAR recommendations were translated and adapted to Italian context. Further evidences were collected about non-pharmacological therapies, local treatments, intra-articular injection with SYSADOA and corticosteroids, and surgery. The SIR has developed updated recommendations for the management of hand OA adapted to the Italian healthcare system. Their implementation in clinical practice is expected to improve the management of patients with hand OA.
- Published
- 2013
25. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR)
- Author
-
Scire', C, Manara, M, Cimmino, M, Govoni, M, Salaffi, F, Punzi, L, Monti, M, Carrara, G, Montecucco, C, Matucci Cerinic, M, Minisola, G, Collaborators, K, SCIRE', Carlo Alberto, Manara M, Cimmino MA, GOVONI, Marcello, Salaffi F, Punzi L, Monti MC, Carrara G, Montecucco C, Matucci Cerinic M, Minisola G, Collaborators K.S., Scire', C, Manara, M, Cimmino, M, Govoni, M, Salaffi, F, Punzi, L, Monti, M, Carrara, G, Montecucco, C, Matucci Cerinic, M, Minisola, G, Collaborators, K, SCIRE', Carlo Alberto, Manara M, Cimmino MA, GOVONI, Marcello, Salaffi F, Punzi L, Monti MC, Carrara G, Montecucco C, Matucci Cerinic M, Minisola G, and Collaborators K.S.
- Abstract
Introduction: Gout is the most prevalent arthritis and significantly impacts on function and quality of life. Given that gout associates with disabling comorbid conditions, it is not clear whether such a complex of diseases accounts for the increased disability or if gout may play a role by itself. This study aims to evaluate the specific influence of gout and disease-related features on functional disability and health-related quality of life (HRQoL) in patients with gout followed in rheumatology clinics.Methods: A random sample of patients was drawn from clinical registries of 30 rheumatology clinics across Italy. Sociodemographic, general health and gout-specific variables were collected. Functional disability and HRQoL were assessed by the health assessment questionnaire (HAQ) and the Physical and Mental Component Summary scores (PCS and MCS) of the Short Form-36 (SF-36). Crude and adjusted ordinal logistic and linear regression models were applied to investigate the specific contribution of different variables on HAQ and SF-36 scores. Results are presented as odds ratio (OR) or mean difference (MD) and 95% confidence intervals.Results: Out of 446 patients with gout, 90% were males with a mean age of 63.9 years and median disease duration of 3.8 years; the majority of patients were overweight or obese, and with several comorbidities; 21.1% showed at least moderate disability; the PCS score was significantly lower than expected age- and gender-matched samples in the general population, while MCS score was not. After adjusting for potential sociodemographic and general-health confounders, gout-specific variables significantly impacted on HAQ, including polyarticular involvement OR 3.82 (1.63, 8.95), presence of tophi OR 1.92 (1.07, 3.43) and recent attacks OR 2.20 (1.27, 3.81). Consistent results were found for PCS. The impairment of PCS compared to the general population was limited to patients with features of chronic gout. MCS was only affected by recent attack
- Published
- 2013
26. AB1099 Counselling on family planning and contraception, and pregnancy outcome in women with rheumatic diseases: a national survey of 398 patient-reported questionnaires from 24 rheumatology centers
- Author
-
Lazzaroni, MG, primary, Dall'Ara, F, additional, Andreoli, L, additional, Carini, C, additional, Rodrigues, M, additional, Reggia, R, additional, Bartoloni-Bocci, E, additional, Gerli, R, additional, Chighizola, CB, additional, Gerosa, M, additional, Meroni, PL, additional, Sinigaglia, L, additional, Conigliaro, P, additional, Perricone, R, additional, Corrado, A, additional, Cantatore, FP, additional, D'Angelo, S, additional, Olivieri, I, additional, Favaro, M, additional, Doria, A, additional, Ruffatti, A, additional, Generali, E, additional, Selmi, C, additional, Meroni, M, additional, Cutolo, M, additional, Padovan, M, additional, Govoni, M, additional, Pazzola, G, additional, Salvarani, C, additional, Peccatori, S, additional, Paolazzi, G, additional, Prevete, I, additional, Sebastiani, GD, additional, Minisola, G, additional, Brucato, A, additional, Ramoni, V, additional, Caporali, R, additional, Montecucco, C, additional, Tani, C, additional, Mosca, M, additional, Trevisani, M, additional, Malavolta, N, additional, Vadacca, M, additional, Afeltra, A, additional, Vivaldelli, E, additional, Maier, A, additional, Baldissera, E, additional, Visalli, E, additional, Foti, R, additional, Zuliani, L, additional, Gabrielli, A, additional, Romeo, N, additional, and Tincani, A, additional
- Published
- 2017
- Full Text
- View/download PDF
27. THU0611 Long-term follow-up of 269 children born to mothers with systemic autoimmune diseases: a national survey from 24 rheumatology centers
- Author
-
Nalli, C, primary, Andreoli, L, additional, Carini, C, additional, Rodrigues, M, additional, Dall'Ara, F, additional, Lazzaroni, MG, additional, Bartoloni-Bocci, E, additional, Chighizola, CB, additional, Campochiaro, C, additional, Conigliaro, P, additional, Corrado, A, additional, D'Angelo, S, additional, Favaro, M, additional, Generali, E, additional, Gerosa, M, additional, Larosa, M, additional, Meroni, M, additional, Padovan, M, additional, Pazzola, G, additional, Peccatori, S, additional, Prevete, I, additional, Ramoni, V, additional, Sebastiani, G, additional, Signorini, V, additional, Tani, C, additional, Trevisani, M, additional, Vadacca, M, additional, Vivaldelli, E, additional, Visalli, E, additional, Zuliani, L, additional, Afeltra, A, additional, Baldissera, E, additional, Brucato, A, additional, Cantatore, FP, additional, Caporali, R, additional, Cutolo, M, additional, Doria, A, additional, Foti, R, additional, Gabrielli, A, additional, Gerli, R, additional, Govoni, M, additional, Maier, A, additional, Malavolta, N, additional, Meroni, PL, additional, Minisola, G, additional, Montecucco, CM, additional, Mosca, M, additional, Olivieri, I, additional, Paolazzi, G, additional, Perricone, R, additional, Romeo, N, additional, Ruffatti, A, additional, Sabbadini, MG, additional, Salvarani, C, additional, Selmi, C, additional, Sinigaglia, L, additional, and Tincani, A, additional
- Published
- 2017
- Full Text
- View/download PDF
28. Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy
- Author
-
Rossini, M, D'Avola, G, Muratore, M, Malavolta, N, Silveri, F, Bianchi, G, Frediani, B, Minisola, G, Sorgi, Ml, Varenna, M, Foti, Rosario, Tartarelli, G, Orsolini, G, Adami, S, Study Group on Osteoporosis, Metabolic Skeletal Diseases of the Italian Society of Rheumatology CollaboratorsAdami, Study Group on Osteoporosis, CollaboratorsAdami S, Metabolic Skeletal Diseases of the Italian Society of R. h. e. u. m. a. t. o. l. o. g. y., Bagnato, G, Cacace, E, Caminiti, M, Cantatore, F, Del Puente, A, Di Munno, O, Ferri, Clodoveo, Iagnocco, Am, La Montagna, G, Maddali Bongi, S, Sinigaglia, L, Tartarelli, G., Rossini, M, D'Avola, G, Muratore, M, Malavolta, N, Silveri, F, DEL PUENTE, Antonio, Bianchi, G, Frediani, B, Minisola, G, Sorgi, Ml, Varenna, M, Foti, R, Tartarelli, G, Orsolini, G, and Adami, S.
- Subjects
Male ,rheumatoid arthritis ,lcsh:Internal medicine ,medicine.medical_specialty ,vitamin D ,disease activity ,lcsh:Medicine ,Arthritis ,Disease ,Severity of Illness Index ,vitamin D deficiency ,Arthritis, Rheumatoid ,Rheumatology ,Rheumatoid ,Internal medicine ,Severity of illness ,Prevalence ,Vitamin D and neurology ,Humans ,Medicine ,Disease activity ,Vitamin D ,lcsh:RC31-1245 ,Body mass index ,Disability ,Nrheumatoid arthritis ,Female ,Italy ,Middle Aged ,Vitamin D Deficiency ,business.industry ,lcsh:R ,VITAMIN-D METABOLISM ,medicine.disease ,Rheumatoid arthritis ,Rheumatoid arthritis, Vitamin D, Disease activity, Disability, Body mass index ,Physical therapy ,business - Abstract
Vitamin D deficiency is very common in patients with rheumatoid arthritis (RA). Aim of this study was to evaluate the prevalence of vitamin D deficiency among the different Italian regions and whether these variations are associated with different severity of the disease. The study includes 581 consecutive RA patients (464 women), not taking vitamin D supplements, from 22 Italian rheumatology centres uniformly distributed across Italy. Together with parameters of disease activity (disease activity score 28), functional impairment (activities of daily living and health assessment questionnaire disability index) and mean sun exposure time, all patients had serum 25-hydroxyvitamin D (25OHD) measured in a centralized laboratory. Vitamin D deficiency (25OHD level
- Published
- 2013
29. Comorbidity in Subjects with Osteoporosis or Fractures: a Cross Sectional Survey (AMICOStudy, Italian Multicentric Analysis on Comorbidities in Osteoporosis)
- Author
-
Gennari L, Gonnelli S, D'Avola G, D'Erasmo E, Di Matteo L, Di Munno O, Fiore C, Gandolini G, Gatto S, Isaia G, Malavolta N, Martini G, Minisola G, Muratore M, Merlotti D, Rotatori S, Alessi C, Nuti R., IOLASCON, Giovanni, Gennari, L, Gonnelli, S, D'Avola, G, D'Erasmo, E, Di Matteo, L, Di Munno, O, Fiore, C, Gandolini, G, Gatto, S, Iolascon, Giovanni, Isaia, G, Malavolta, N, Martini, G, Minisola, G, Muratore, M, Merlotti, D, Rotatori, S, Alessi, C, and Nuti, R.
- Published
- 2013
30. DRUG SURVIVAL OF THE FIRST COURSE OF ANTI-TNF AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLOARTHROPATHIES. RESULTS FROM THE MONITORNET DATABASE
- Author
-
CAPORALI R, SCIRE CA, TODOERTI M, GALEAZZI M, VALESINI G, SFRISO P, FILIPPINI M, SARZI PUTTINI P. PELLERITO R. DEL SANTE G, MATIHIEU A, SINIGAGLIA L, SALAFFI F, MINISOLA G, MONTECUCCO C, TODESCO S., TIRRI, Rosella, Caporali, R, Scire, Ca, Todoerti, M, Galeazzi, M, Valesini, G, Sfriso, P, Tirri, Rosella, Filippini, M, SARZI PUTTINI P. PELLERITO R., DEL SANTE G, Matihieu, A, Sinigaglia, L, Salaffi, F, Minisola, G, Montecucco, C, and Todesco, S.
- Published
- 2012
31. Determinants and effects of vitamin D supplementation on serum 25-Hydroxy-vitamin D levels in patients with rheumatoid arthritis
- Author
-
Varenna, M., Maria Manara, Cantatore, F. P., Del Puente, A., Di Munno, O., Malavolta, N., Minisola, G., Adami, S., Sinigaglia, L., Rossini, M., Varenna, M, Manara, M, Cantatore, Fp, DEL PUENTE, Antonio, Di Munno, O, Malavolta, N, Minisola, G, Adami, S, Sinigaglia, L, and Rossini, M.
- Subjects
rheumatoid arthritis ,vitamin D ,25-hydroxy-vitamin D - Published
- 2012
32. Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee
- Author
-
Salaffi, F., Leardini, G., Canesi, B., Mannoni, A., Fioravanti, A., Caporali, R., Lapadula, G., Punzi, L., Bucci, R., Cimmino, M. A., Ciocci, A., Colombo, F., Frizziero, L., Grattagliano, V., Magaro, M., Mascia, Maria Teresa, Minisola, G., Modena, V., Muratore, M., Nervetti, A., R, Olivieri, I., Perpignano, G., Rossi, S., Sabadini, L., Sarzi Puttini, P., Schiavon, F., Spano, A., Stancati, A., Stisi, S., Telese, F., and Tirri, G.
- Subjects
Male ,musculoskeletal diseases ,medicine.medical_specialty ,Osteoarthritis of the knee ,WOMAC ,Wilcoxon signed-rank test ,Intraclass correlation ,Biomedical Engineering ,Pain ,Comorbidity ,Osteoarthritis ,trial methodology ,Health status ,Cohort Studies ,Disability Evaluation ,Trial methodology ,Physical medicine and rehabilitation ,Cronbach's alpha ,Rheumatology ,Surveys and Questionnaires ,medicine ,Humans ,Outpatient clinic ,Knee ,Orthopedics and Sports Medicine ,Muscle, Skeletal ,Aged ,Aged, 80 and over ,business.industry ,Discriminant validity ,Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index ,Reproducibility of Results ,Construct validity ,osteoarthritis ,Middle Aged ,Osteoarthritis, Knee ,medicine.disease ,humanities ,Cross-Sectional Studies ,Italy ,Physical therapy ,Female ,business - Abstract
Objective : The Western Ontario and McMaster Universities (WOMAC) Osteoarthritis (OA) Index is a tested questionnaire to assess symptoms and physical functional disability in patients with OA of the knee and the hip. We adapted the WOMAC for the Italian language and tested its metric properties in 304 patients with symptomatic OA of the knee. Methods : Three hundred and four consecutive patients, attending 29 rheumatologic outpatient clinic in northern, central, and southern Italy, were asked to answer two disease-specific questionnaires (WOMAC and Lequesne algofunctional index) and one generic instrument (Medical Outcomes Study SF-36 Health Survey—MOS SF-36). A sample of 258 patients was readministered the WOMAC 7–10 days after the first visit and the structured interview, which also assessed demographic and other characteristics. Internal consistency was assessed using Cronbach's alpha, reliability using intraclass correlation coefficients (ICCs), and construct and discriminant validity using Spearman's correlations, Wilcoxon rank sum test, and Kruskal–Wallis test. Results : All WOMAC subscales (pain, stiffness, and physical function) were internally consistent with Cronbach's coefficient alpha of 0.91, 0.81, and 0.84, respectively. Test–retest reliability was satisfactory with ICCs of 0.86, 0.68, and 0.89, respectively. In comparison with the SF-36, the expected correlations were found when comparing items measuring similar constructs, supporting the concepts of convergent construct validity. Very high correlations were also obtained between WOMAC scores and Lequesne OA algofunctional index. WOMAC physical function, but not WOMAC stiffness and pain subscales, was weakly associated with radiological OA severity ( P =0.03). Also, WOMAC pain score was inversely correlated ( P =0.01) with years of formal education. Examination of discriminant validity showed that the scores on the WOMAC and SF-36 followed hypothesized patterns: the WOMAC discriminated better among subjects with varying severity of knee problems, whereas the SF-36 discriminated better among subjects with varying levels of self-reported health status and comorbidity. Conclusion : The Italian version of WOMAC is a reliable and valid instrument for evaluating the severity of OA of the knee, with metric properties in agreement with the original, widely used version.
- Published
- 2003
- Full Text
- View/download PDF
33. Lifestyle and dietary habits of patients with gout followed in rheumatology settings
- Author
-
Manara, M., primary, Carrara, G., additional, Scirè, C. A., additional, Cimmino, M. A., additional, Govoni, M., additional, Montecucco, C., additional, Matucci-Cerinic, M., additional, Minisola, G., additional, and Study group, The KING, additional
- Published
- 2016
- Full Text
- View/download PDF
34. A validation study of a new classification algorithm to identify rheumatoid arthritis using administrative health databases: Case-control and cohort diagnostic accuracy studies. Results from the RECord linkage on Rheumatic Diseases study of the Italian Society for Rheumatology
- Author
-
Carrara, G, Scirè, C, Zambon, A, Cimmino, M, Cerra, C, Caprioli, M, Cagnotto, G, Nicotra, F, Arfè, A, Migliazza, S, Corrao, G, Minisola, G, Montecucco, C, ZAMBON, ANTONELLA, NICOTRA, FEDERICA, CORRAO, GIOVANNI, Montecucco, C., Carrara, G, Scirè, C, Zambon, A, Cimmino, M, Cerra, C, Caprioli, M, Cagnotto, G, Nicotra, F, Arfè, A, Migliazza, S, Corrao, G, Minisola, G, Montecucco, C, ZAMBON, ANTONELLA, NICOTRA, FEDERICA, CORRAO, GIOVANNI, and Montecucco, C.
- Abstract
Objectives: To develop and validate a new algorithm to identify patients with rheumatoid arthritis (RA) and estimate disease prevalence using administrative health databases (AHDs) of the Italian Lombardy region. Design: Case-control and cohort diagnostic accuracy study. Methods: In a randomly selected sample of 827 patients drawn from a tertiary rheumatology centre (training set), clinically validated diagnoses were linked to administrative data including diagnostic codes and drug prescriptions. An algorithm in steps of decreasing specificity was developed and its accuracy assessed calculating sensitivity/specificity, positive predictive value (PPV)/negative predictive value, with corresponding CIs. The algorithm was applied to two validating sets: 106 patients from a secondary rheumatology centre and 6087 participants from the primary care. Alternative algorithms were developed to increase PPV at population level. Crude and adjusted prevalence estimates taking into account algorithm misclassification rates were obtained for the Lombardy region. Results: The algorithms included: RA certification by a rheumatologist, certification for other autoimmune diseases by specialists, RA code in the hospital discharge form, prescription of disease-modifying antirheumatic drugs and oral glucocorticoids. In the training set, a four-step algorithm identified clinically diagnosed RA cases with a sensitivity of 96.3 (95% CI 93.6 to 98.2) and a specificity of 90.3 (87.4 to 92.7). Both external validations showed highly consistent results. More specific algorithms achieved >80% PPV at the population level. The crude RA prevalence in Lombardy was 0.52%, and estimates adjusted for misclassification ranged from 0.31% (95% CI 0.14% to 0.42%) to 0.37% (0.25% to 0.47%). Conclusions: AHDs are valuable tools for the identification of RA cases at the population level, and allow estimation of disease prevalence and to select retrospective cohorts.
- Published
- 2015
35. Differenze regionali della carenza di vitamina D in pazienti affetti da artrite reumatoide in Italia
- Author
-
Rossini, M, D'Avola, G, Muratore, M, Malavolta, N, Silveri, F, Bianchi, G, Frediani, B, Minisola, G, Sorgi, Ml, Varenna, M, Foti, R, Tartarelli, G, Orsolini, G, Adami, S, Bagnato, G, Cacace, E, Caminiti, M, Cantatore, F, G, Del Puente, A, Di Munno, O, Ferri, C, Iagnocco, Am, La Montagna, G, Maddali Bongi, Susanna, and Sinigaglia, L
- Subjects
Arthritis, Rheumatoid ,Female ,Humans ,Italy ,Male ,Middle Aged ,Prevalence ,Severity of Illness Index ,Vitamin D Deficiency - Published
- 2013
36. Development and Preliminary Validation of a Candidate Disease Activity Score for Gout
- Author
-
Minisola, G., Matucci-Cerinic, M., CARLOMAURIZIO MONTECUCCO, Salaffi, F., Govoni, M., Cimmino, M. A., Manara, M., Viroli, C., Scire, C. A., C.A. Scirè, C. Viroli, M. Manara, M.A. Cimmino, M. Govoni, F. Salaffi, C. Montecucco, M. Matucci-Cerinic, and G. Minisola
- Subjects
musculoskeletal diseases ,DISEASE - Abstract
Disease activity has been operatively defined as presence of urate deposits that lead to acute arthritis and joint damage. Every item of the pool of measures for each core domain recommended by OMERACT for trials in gout was tested for suitability in defining the concept of disease activity through a Delphi exercise. A three-step approach, similar to the methodology used for the disease activity score in rheumatoid arthritis, was applied to derive the gout activity score (GAS). Decision to change treatment was used as surrogate criterion of high disease activity. Baseline and 12-month follow-up data of 446 patients included in the KING cohort (Kick-off of the Italian Network for Gout) were used. Data included measures of all domains identified as important for trials in gout. Construct and criterion-related validity were preliminary tested using risk of flare and cross-sectional and longitudinal health assessment questionnaire score (HAQ).
- Published
- 2013
37. Approach in glucocorticoid-induced osteoporosis prevention: results from the Italian multicenter observational EGEO study
- Author
-
Massafra, U., Migliaccio, S., Bancheri, C., Chiacchiarelli, F., Fantini, F., Leoni, F., Martin, L. S., Migliore, A., Muccifora, B., Napolitano, C., Pastore, R., Ragno, A., Ronzoni, S., Rotondi, M., Tibaldi, M., Villa, P., Vinicola, V., D'Erasmo, E., Falaschi, Paolo, and Minisola, G.
- Subjects
Adult ,Aged, 80 and over ,Male ,Settore MED/13 - ENDOCRINOLOGIA ,Middle Aged ,Cohort Studies ,Young Adult ,Settore MED/40 - GINECOLOGIA E OSTETRICIA ,Italy ,Bone Density ,Humans ,Osteoporosis ,glucocorticoid ,Female ,Prospective Studies ,Glucocorticoids ,Aged - Abstract
Glucocorticoid-induced osteoporosis (GIO) is the most frequent cause of secondary osteoporosis. GIO is linked to glucocorticoids (GC) daily assumption with maximum effect within first months of treatment and decreasing to basal levels as the therapy is discontinued. In Italy, primary prevention of GIO is suggested when GC therapy (prednisone5 mg/day or equivalent) is taken for longer than 3 months. Lazio GISMO (Italian Group for Study and Diagnosis of Bone Metabolism Diseases) group organized the GC and Osteoporosis Epidemiology study (EGEO) to evaluate physician's approach in preventing GIO. The study involved 19 osteoporosis centers. Patients taking long-term GC therapy were recruited and information collected: medical history and anthropometric data, GC therapy, primary disease, physician's specialty, osteopororosis screening, and pharmacological intervention. The study included 1334 patients. Mean age was 63 ± 13 yr; 243 (18%) patients had a history of falls from standing position in the previous 12 months, 78 (35%) vertebral fractures, 91 (41%) fractures other than vertebral, 27 (12%) femoral fractures, and 27 (12%) multiple sites fractures. The molecules of GC more often prescribed were prednisone and 6-metil prednisolone. One thousand and forty patients (78%) were taking GC for more than 6 months. GC therapy was prescribed more frequently by rheumatologists (62%). Antiosteoporotic drugs for GIO prevention were prescribed in 431 patients (32%). Among the patients, only 27% (360) received calcium and vitamin D supplements, and 39% (319) treated by rheumatologists received anti-resorptive drugs. In conclusion, our data show that in Italy, as already described elsewhere, only a small subpopulation of GC-treated patients was supported by an anti-osteoporotic therapy, indicating the need to further stimulate awareness of both patients and specialists, prescribing GC therapy, to an appropriate and prompt GIO prevention.
- Published
- 2012
38. The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis
- Author
-
Ceccarelli, F., D Alfonso, S., Carlo Perricone, Carlomagno, Y., Alessandri, C., Croia, C., Barizzone, N., Montecucco, C., Galeazzi, M., Sebastiani, G. D., Minisola, G., Fiocco, U., and Valesini, G.
- Subjects
Adult ,Male ,Pore Forming Cytotoxic Proteins ,rheumatoid arthritis ,Time Factors ,Adolescent ,Hydrolases ,anti-tnf ,Peptides, Cyclic ,Polymorphism, Single Nucleotide ,White People ,Arthritis, Rheumatoid ,prf1 ,Young Adult ,Protein-Arginine Deiminase Type 4 ,padi4 ,Rheumatoid Factor ,Odds Ratio ,Humans ,Genetic Predisposition to Disease ,opn ,Aged ,Autoantibodies ,Aged, 80 and over ,Chi-Square Distribution ,Perforin ,Tumor Necrosis Factor-alpha ,Middle Aged ,Phenotype ,Treatment Outcome ,Italy ,Antirheumatic Agents ,Case-Control Studies ,Multivariate Analysis ,Linear Models ,Protein-Arginine Deiminases ,Female ,Osteopontin ,Biomarkers ,HLA-DRB1 Chains - Abstract
Several single nucleotide polymorphisms (SNPs) have been associated with rheumatoid arthritis (RA) such as peptidylarginine deiminase-4 (PADI4), osteopontin (OPN), and perforin (PRF1) genes. Thus, we aimed at analysing the influence of eight SNPs in these candidate genes on RA susceptibility and their association with laboratory and clinical features in terms of response to anti-TNF therapy.We performed a case-control study on 377 Caucasian RA patients and 391 healthy, ethnicity-matched, population-based controls. All subjects were genotyped for PADI4_89/94, PADI4_92, PADI4_104, PADI4_100 in PADI4; -156G/GG and +1239A/C in OPN and A91V and N252S in PRF1 genes. The patients were stratified for shared epitope (SE) HLA-DRB1. rheumatoid factor (RF) and anti-citrullinated protein/peptide antibodies (ACPA) were analysed. The patients started anti-TNF treatment and they were evaluated at baseline and after 12 weeks. Disease activity was evaluated with DAS28 and response to treatment with EULAR criteria.A statistically significant association between RA and OPN -156G/GG was found (p=0.023). SE was firmly confirmed to be associated with RA (OR=3.68; p10-10). No other statistically significant association with clinical and laboratory features were observed.For the first time, in an Italian cohort, we report the association between -156G/GG in OPN gene and RA susceptibility. Short-term response to anti-TNF therapy was not influenced by the genetic variants studied.
- Published
- 2012
39. SOPRAVVIVENZA IN TRATTAMENTO AL PRIMO ANTI-TNF IN PAZIENTI CON ARTRITE REUMATOIDE E SPONDILOARTOPATIE. ANALISI DAL REGISTRO MONITORNET
- Author
-
R. Caporali, C. A. Scirè, Todoerti, M., Galeazzi, M., Valesini, Guido, Sfriso, P., Tirri, R., Filippini, M., Sarzi Puttini, P., Pellerito, R., Delsante, G., Mathieu, A., Sinigaglia, L., Salaffi, F., Minisola, G., Montecucco, C., Todesco, S., and co authors, Monitornet
- Published
- 2012
40. [Biotechnological innovation to the benefit of the rheumatic patient]
- Author
-
Minisola G
- Subjects
Drug Utilization ,lcsh:Internal medicine ,medicine.medical_specialty ,Treatment outcome ,MEDLINE ,lcsh:Medicine ,Models, Biological ,Text mining ,Rheumatology ,Cost of Illness ,Rheumatic Diseases ,medicine ,Cost of illness ,Humans ,lcsh:RC31-1245 ,Intensive care medicine ,Medical Assistance ,business.industry ,Therapies, Investigational ,lcsh:R ,Europe ,Treatment Outcome ,Italy ,Antirheumatic Agents ,Diffusion of Innovation ,Health Expenditures ,business ,Goals - Abstract
NOT AVAILABLE
- Published
- 2011
41. Seasonal and regional variations in the prevalence of vitamin D insufficiency in patiens with theumatoid arthritis
- Author
-
Idolazzi, Luca, Antonelli, M, Rossini, Maurizio, Bagnato, G, Minisola, G, and Adami, Silvano
- Subjects
vitamin D insufficiency - Published
- 2011
42. Over-expression of miR-223 in T-lymphocytes of early rheumatoid arthritis patients
- Author
-
Sebastiani, G. D., valerio fulci, Niccolini, S., Giannitti, C., Bugatti, S., Minisola, G., Barnaba, V., Scappucci, G., Macino, G., and Galeazzi, M.
- Subjects
Adult ,Aged, 80 and over ,Arthritis, Rheumatoid ,Male ,MicroRNAs ,Gene Expression Regulation ,T-Lymphocytes ,Humans ,Female ,Cell Separation ,Middle Aged ,Aged - Published
- 2011
43. SAT0196 Dekavil (F8-IL10), A Novel Therapeutic Approach for Rheumatoid Arthritis: Ongoing Phase IB Clinical Trial Results
- Author
-
Galeazzi, M., primary, Sebastiani, G.D., additional, Bazzichi, L., additional, Garcia Gonzalez, E., additional, Ravenni, N., additional, Giovannoni, L., additional, Wilton, J., additional, Selvi, E., additional, Bardelli, M., additional, Baldi, C., additional, Iuliano, A., additional, Minisola, G., additional, Caporali, R., additional, Bombardieri, S., additional, and Neri, D., additional
- Published
- 2015
- Full Text
- View/download PDF
44. A validation study of a new classification algorithm to identify rheumatoid arthritis using administrative health databases: case-control and cohort diagnostic accuracy studies. Results from the RECord linkage On Rheumatic Diseases study of the Italian Society for Rheumatology
- Author
-
Carrara, G., primary, Scire, C. A., additional, Zambon, A., additional, Cimmino, M. A., additional, Cerra, C., additional, Caprioli, M., additional, Cagnotto, G., additional, Nicotra, F., additional, Arfe, A., additional, Migliazza, S., additional, Corrao, G., additional, Minisola, G., additional, and Montecucco, C., additional
- Published
- 2015
- Full Text
- View/download PDF
45. Use of Probiotics in the Prevention and Treatment of Radiation Enteritis
- Author
-
Famularo, G, Trinchieri, Vito, Mosca, Luciana, and Minisola, G.
- Published
- 2010
46. Patient preferences in the choice of anti-TNF therapies in heumatoid arthritis. Results from a questionnaire survey (RIVIERA study)
- Author
-
Scarpato, S., Antivalle, M., Favalli, E. G., Nacci, F., Frigelli, S., Bartoli, F., Bazzichi, L., Minisola, G., Matucci Cerinic, M., Salvarani, Carlo, Altucci, P, Bombardieri, S, Battaglia, E, Ferri, Clodoveo, Pozzi, Mr, Afeltra, A, Bersi, M, Tartarelli, G, Montecucco, Cm, Altomare, E, Bambara, Lm, Bucci, R, Colombelli, Pl, Corsaro, S, Rinaldi, F, Sinigaglia, L, Trotta, F, Carrabba, M, Migliore, A, Bianchi, G, Grassi, W, Rocchetta, Pa, Altomonte, L, Coaccioli, S, Danieli Armando, G, Perpignano, G, Broggini, M, Morassi, P, Peronato, G, Canesi, B, Delsante, G, Di Giuseppe, P, Di Rosa SO, Gorla, R, Malavolta, N, Solinas, F, Todesco, S, Varcasia, G, Versace, F, Sabadini, L, Del Giacco, S, Marasini, B, Bagnato, G, Gerli, R, Modena, V, and Di Piazza, V.
- Subjects
rheumatoid arthritis ,Adult ,Male ,medicine.medical_specialty ,Adolescent ,Rheumatoid arthritis ,Anti-TNF therapy ,Decision making ,Patient empowerment ,Arthritis ,Self Administration ,Infusions, Subcutaneous ,Choice Behavior ,Arthritis, Rheumatoid ,Route of administration ,Young Adult ,Rheumatology ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Young adult ,RIVIERA study ,anti-TNF therapies ,Infusions, Intravenous ,Aged ,Response rate (survey) ,Aged, 80 and over ,business.industry ,Tumor Necrosis Factor-alpha ,Questionnaire ,Patient Preference ,Middle Aged ,medicine.disease ,Italy ,Antirheumatic Agents ,Physical therapy ,Female ,Analysis of variance ,business ,Epidemiologic Methods - Abstract
Objective. To identify the determinants of anti-TNF-naive patients’ preferences for the route of administration of anti-TNF agents. Methods. The study was carried out in 50 Italian rheumatology centres (802 patients). All patients completed a 31-item questionnaire addressing their perceptions of current treatment and the preferences for treatment with anti-TNF agents. Statistical methods included analysis of variance (ANOVA), t-test and chi-square test. Results. The response rate to the questionnaire was 97.6%. At the time of the survey, 310 (39.9%) patients were dissatisfied with current treatments, owing to inefficacy, side effects and inconvenience of administration. The i.v. and s.c. routes of administration were preferred by 50.2 and 49.8%, respectively. No significant difference was found in patients by gender, age, RA duration or number of drugs used. Reasons for the choice of i.v. administration were the safety of treatment at the hospital and the reassuring effect of physician presence. The s.c. administration was chosen for the convenience of treatment and in particular for home treatment. Patients dissatisfied with current therapy due to side effects preferred s.c. administration (P ¼ 0.029), whereas patients choosing the i.v. route had slightly higher scores on ‘today pain’ (P ¼ 0.047) and ‘articular pain’ (P ¼ 0.023) of the Rheumatoid Arthritis Disease Activity Index (RADAI). Conclusions. Both i.v. and s.c. treatments were well accepted by patients. However, treatment choice has to be discussed with patients, as individual preference seems to be determined by personal attitudes towards safety and convenience, by past experience and by the perception of current disease status.
- Published
- 2010
47. Use of drugs for bone loss prevention in 808 italian patients with rheumatoid arthritis treated with glucocorticoids
- Author
-
Massafra, U., Rossini, M., Sorgi, Maria Laura, Antonelli, M., Marini, M., Caporuscio, S., Migliore, A., and Minisola, G.
- Published
- 2010
48. Appropriate use of anabolic treatment for severe osteoporosis
- Author
-
Adami, S, Brandi, M, Canonico, P, Minisola, G, Minisola, S, and Tarantino, U
- Subjects
teriparatide ,antiresorptives ,anabolic treatment ,severe osteoporosis ,cost effectiveness ,fractures ,Settore MED/33 - Malattie Apparato Locomotore ,Mini-Review - Abstract
Osteoporotic fractures remain a major public health problem for their correlated morbidity and mortality. The primary aim of therapy must be the prevention of the first fragility fracture and avoiding subsequent fractures in patients who already have an existing fracture. There are evidences from randomized controlled trials (RCTs) about the efficacy of antiresorptives, such as bisphosphonates in reducing the risk of fracture, but none of these agents completely abolish the fracture risk. The reduction of RRR by different therapies in RCTs is relatively constant but it is important to note that the proportion of inadequate-responders (i.e.: patients fracturing despite adequate pharmacological treatment) is increasing with the severity of the disease: the higher the risk of fracture the higher the proportion of inadequate-responders. Thus, the proportion of non responders across different trials is directly related to the fracture incidence observed in the control group of RCTs which is the most proximate indicator of osteoporosis severity.Teriparatide (TPTD) demonstrate a real increases of both trabecular and cortical bone volume, which are associated with a true reduction of fracture risk, as many RCTs confirm. The beneficial effect of introducing a treatment with antiresorptives after the treatment course with TPTD has been clearly demonstrated with the prevention of the reabsorption of the new bone tissue built during TPTD therapy and rapidly lowers cortical porosity, which leads to further increases in BMD. For these results, the introduction of an anti-resorptive after the treatment course with TPTD is strongly recommended and taken into account.In Italy TPTD is fully reimbursed in patients incurring in a new vertebral or hip fracture while on chronic treatment with antiresorptive or in naive patients with 3 or more vertebral or hip fractures. In conclusion, since patients with severe osteoporosis are at very high risk of new fractures with worsening of quality of life and life expectancy, antiresorptives represent a sub-optimal treatment in these patients, werehas, since TPTD demonstrated real and substantial improvements in bone mass and reduction of fracture risk independently of initial risk, TPTD represents the only therapeutic option able to reverse at least in part this disabling disease.
- Published
- 2010
49. The relationship between focal erosions, bone mineral density and parathyroid hormone levels in rheumatoid arthritis
- Author
-
Benini, C., Antonelli, M., Bagnato, G., Bianchi, G., Caminiti, M., Cantatore, F. P., Del Puente, A., Frediani, B., Iagnocco, A., Minisola, G., Muratore, M., Rossini, M., Sorgi, Maria Laura, and Adami, S.
- Published
- 2010
50. Glucocorticoid induce osteoporis: preliminary data from the multicentric EGEO (Evaluation and Epidemiology of Glucocorticoid Induced Osteoporosis) Study
- Author
-
Massafra, U., Antonelli, M., Marini, M., Vinicola, V., Migliore, A., Falaschi, Paolo, D'Erasmo, E., and Minisola, G.
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.